🟢 Park Ha Biological Technology is trading 7.14% up in pre-market after announcing $2.97 million private placement

Park Ha Biological Technology is trading 7.14% up in pre-market at $2.55 after announcing a $2.97 million private placement.

• The financing was announced on September 11, 2026, and includes 1,080,000 Class A ordinary shares and warrants for 1,845,452 additional shares.
• The issuance is potentially dilutive.
• The company-specific financing appears to be the clearest catalyst for the September 14 pre-market move; broader markets are weaker, so general sentiment does not explain the gain.